Answers are grounded in this paper and cite their sources.
Although natural-killer-cell therapies are safer than T-cell therapies and offer other advantages, they require upgrades to overcome their limited lifespan and susceptibility to immunosuppression. Although natural-killer-cell therapies are safer than T-cell therapies and offer other advantages, they require upgrades to overcome their limited lifespan and susceptibility to immunosuppression.
No takes yet. Share an insight, caveat, or question.
Amanda B. Keener (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: